On (b)(6) 2018, a patient (pt) from (b)(6) wearing 1-day acuvue trueye contact lenses (cls) reported that in (b)(6) 2018 the pt experienced irritation, redness, and pain after removal of the cl and visited an eye care professional (ecp).The pt was diagnosed with keratitis in the left eye (os).The pt was prescribed antibacterial eye drops (unspecified name, dosage, duration) and was instructed to discontinue cl wear for two weeks.The pt¿s os is currently recovered.The suspect product was discarded.On (b)(6) 2018, the pt was contacted and reported that the eye drops that were prescribed were gatiflo eye drops 0.3% (gatifloxacin hydrate), to be applied every 2-3 hours for the first 3 days until the follow-up visit and then tid.The pt revisited the clinic after a week from the follow-up visit and was diagnosed with recovery and was instructed to discontinue the gatiflo eye drops.Additional information is not available as the patient refused consent to contact the treating ecp.A lot history review was performed and revealed the following: the batch record did not show any abnormalities in monomer and solution testing.All parameters tested were within specification.All sterilization requirements were successfully completed.Lot 5829210105 was produced under normal conditions.If additional information is received it will be reported within 30 days of receipt.Serious reportable event trends are reviewed quarterly in franchise management review meetings.
|